Share Capital (Tables)
|
3 Months Ended |
12 Months Ended |
Mar. 31, 2020 |
Dec. 31, 2019 |
Share Capital [Abstract] |
|
|
Summary of shares sold under share purchase agreement |
Between January 3, 2020 and February 13, 2020, the Company issued 4,408,048 common shares pursuant to the Second Aspire Agreement as outlined in the following table:
Grant Date
|
|
|
Common shares
issued
|
|
|
Value
|
|
January 3, 2020
|
|
|
|
500,000
|
|
|
$
|
219,600
|
|
January 6, 2020
|
|
|
|
500,000
|
|
|
|
229,300
|
|
January 8, 2020
|
|
|
|
400,000
|
|
|
|
195,160
|
|
January 10, 2020
|
|
|
|
500,000
|
|
|
|
247,550
|
|
January 17, 2020
|
|
|
|
600,000
|
|
|
|
303,000
|
|
January 23, 2020
|
|
|
|
600,000
|
|
|
|
295,320
|
|
February 6, 2020
|
|
|
|
600,000
|
|
|
|
282,000
|
|
February 13, 2020
|
|
|
|
708,048
|
|
|
|
300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,408,048
|
|
|
$
|
2,071,930
|
|
Subsequent to August 29, 2019 and subject to the First Aspire Agreement, the Company issued
Common Shares to Aspire as outlined in the following table:
Grant Date
|
|
Common shares
issued
|
|
|
Value
|
|
August 30, 2019
|
|
|
2,417,162
|
|
|
$
|
3,000,000
|
|
November 8, 2019
|
|
|
100,000
|
|
|
|
42,560
|
|
November 8, 2019
|
|
|
100,000
|
|
|
|
42,560
|
|
November 12, 2019
|
|
|
100,000
|
|
|
|
42,970
|
|
November 12, 2019
|
|
|
100,000
|
|
|
|
42,000
|
|
November 13, 2019
|
|
|
100,000
|
|
|
|
42,970
|
|
November 14, 2019
|
|
|
300,000
|
|
|
|
128,910
|
|
November 15, 2019
|
|
|
2,500,000
|
|
|
|
1,074,250
|
|
November 19, 2019
|
|
|
2,067,282
|
|
|
|
888,311
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,784,444
|
|
|
$
|
5,304,531
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares issued |
|
|
Value |
|
|
|
|
2,417,162 |
|
|
$ |
3,000,000 |
|
|
|
|
100,000 |
|
|
|
42,560 |
|
|
|
|
100,000 |
|
|
|
42,560 |
|
|
|
|
100,000 |
|
|
|
42,970 |
|
|
|
|
100,000 |
|
|
|
42,000 |
|
|
|
|
100,000 |
|
|
|
42,970 |
|
|
|
|
300,000 |
|
|
|
128,910 |
|
|
|
|
2,500,000 |
|
|
|
1,074,250 |
|
|
|
|
2,067,282 |
|
|
|
888,311 |
|
|
|
|
|
|
|
|
|
|
|
|
|
7,784,444 |
|
|
$ |
5,304,531 |
|
|
|
|
|
|
|
|
|
|
|
Summary of Weighted Average Inputs Used in the Measurement of Fair Values at the Amendment Date of the Share-Based Option Plan |
|
The weighted average inputs used in the measurement of fair values at the amendment date of the share-based option plan are as follows:
|
|
|
|
|
|
|
May 29, 2019 before the amendments |
|
May 29, 2019 after the amendments |
|
|
|
|
|
|
|
CDN $ 3.47
|
|
CDN $ 3.47
|
|
|
|
|
CDN $ 4.54
|
|
|
|
|
|
|
|
years |
|
|
|
|
Nil |
|
Nil |
Risk free interest rate (based on government bonds) |
|
|
|
|
|
Summary of Options Outstanding |
A summary of the status of the Company’s outstanding stock options as of March 31, 2020 and December 31, 2019 and changes during the periods ended on those dates is presented in the
following table:
Stock Options – CDN $ denominated
|
|
Three months ended
March 31, 2020
|
|
|
Year Ended
December 31, 2019
|
|
|
|
Number of
Stock Options(1)
|
|
|
Weighted average
Exercise Price (CDN)
|
|
|
Number of
Stock Options(1)
|
|
|
Weighted average
Exercise Price (CDN)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Beginning
|
|
|
860,379
|
|
|
$
|
5.89
|
|
|
|
875,433
|
|
|
$
|
18.20
|
|
Granted
|
|
|
25,765
|
|
|
|
0.66
|
|
|
|
35,719
|
|
|
|
4.54
|
|
Expired/Forfeited
|
|
|
-
|
|
|
|
-
|
|
|
|
(50,773
|
)
|
|
|
31.79
|
|
Balance Ending
|
|
|
886,144
|
|
|
$
|
5.74
|
|
|
|
860,379
|
|
|
$
|
5.89
|
|
Stock Options – US $ denominated
|
|
Three months ended
March 31, 2020
|
|
|
Year Ended
December 31, 2019
|
|
|
|
Number of
Stock Options
|
|
|
Weighted average
Exercise Price (USD)
|
|
|
Number of
Stock Options
|
|
|
Weighted average
Exercise Price (USD)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Beginning
|
|
|
854,042
|
|
|
$
|
2.65
|
|
|
|
50,349
|
|
|
$
|
1.55
|
|
Granted
|
|
|
-
|
|
|
|
-
|
|
|
|
843,693
|
|
|
|
2.72
|
|
Expired/Forfeited
|
|
|
(467,255
|
)
|
|
|
2.20
|
|
|
|
(40,000
|
)
|
|
|
3.72
|
|
Balance Ending
|
|
|
386,787
|
|
|
$
|
3.19
|
|
|
|
854,042
|
|
|
$
|
2.65
|
|
1.
|
After giving consideration for 30:1 share consolidation effected June 20, 2018.
|
|
A summary of the status of the Company’s outstanding stock options as of December 31, 2019 and December 31, 2018 and changes during the periods ended on those dates is presented in the following table:
Stock Options - CDN $ denominated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2019 |
|
|
December 31, 2018 |
|
|
|
Number of Stock Options |
|
|
Weighted average Exercise Price (CDN) |
|
|
Number of Stock Options (1) |
|
|
Weighted average Exercise Price (CDN) |
|
|
|
|
875,433 |
|
|
$ |
18.20 |
|
|
|
591,609 |
|
|
$ |
21.30 |
|
|
|
|
35,719 |
|
|
|
4.54 |
|
|
|
322,517 |
|
|
|
13.51 |
|
|
|
|
(50,773 |
) |
|
|
31.79 |
|
|
|
(38,693 |
) |
|
|
24.90 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
860,379 |
|
|
$ |
5.89 |
|
|
|
875,433 |
|
|
$ |
18.20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Options - US $ denominated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2019 |
|
|
December 31, 2018 |
|
|
|
Number of Stock Options |
|
|
Weighted average Exercise Price ( USD ) |
|
|
Number of Stock Options (1) |
|
|
Weighted average Exercise Price ( D) |
|
|
|
|
50,349 |
|
|
$ |
1.55 |
|
|
|
— |
|
|
$ |
— |
|
|
|
|
843,693 |
|
|
|
2.72 |
|
|
|
50,349 |
|
|
|
1.55 |
|
|
|
|
(40,000 |
) |
|
|
3.72 |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
854,042 |
|
|
$ |
2.65 |
|
|
|
50,349 |
|
|
$ |
1.55 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1. |
After giving consideration for 30:1 share consolidation effected June 20 , 2018. |
|
Summary of Weighted-Average Remaining Contractual Life and Weighted-Average Exercise Price Options Outstanding and Options Exercisable on Exercise Prices |
The weighted-average remaining contractual life and weighted-average exercise price of options outstanding and of options exercisable as at March 31, 2020 are as follows:
Canadian Dollar Denominated Options |
|
|
|
|
|
|
|
|
|
|
Exercise Price
(CDN)
|
|
Number
Outstanding
|
|
|
Weighted-average
remaining contractual
life (years)
|
|
|
Options
Exercisable
|
|
$0.66
|
|
|
25,765
|
|
|
|
6.83
|
|
|
|
25,765
|
|
$3.28
|
|
|
31,498
|
|
|
|
5.42
|
|
|
|
31,498
|
|
$4.50
|
|
|
18,936
|
|
|
|
3.03
|
|
|
|
18,936
|
|
$4.54
|
|
|
743,122
|
|
|
|
3.99
|
|
|
|
370,354
|
|
$4.80
|
|
|
3,040
|
|
|
|
0.46
|
|
|
|
3,040
|
|
$7.49
|
|
|
5,590
|
|
|
|
5.27
|
|
|
|
5,590
|
|
$9.00
|
|
|
11,481
|
|
|
|
5.27
|
|
|
|
11,481
|
|
$9.60
|
|
|
1,105
|
|
|
|
0.52
|
|
|
|
1,105
|
|
$11.70
|
|
|
6,667
|
|
|
|
0.69
|
|
|
|
6,667
|
|
$12.00
|
|
|
1,948
|
|
|
|
0.68
|
|
|
|
1,948
|
|
$30.00
|
|
|
28,260
|
|
|
|
1.40
|
|
|
|
28,260
|
|
$30.60
|
|
|
2,096
|
|
|
|
0.73
|
|
|
|
2,096
|
|
$32.40
|
|
|
810
|
|
|
|
0.83
|
|
|
|
810
|
|
$45.30
|
|
|
560
|
|
|
|
0.36
|
|
|
|
560
|
|
$51.60
|
|
|
5,266
|
|
|
|
0.19
|
|
|
|
5,268
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
886,144
|
|
|
|
3.96
|
|
|
|
513,378
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
US Dollar Denominated Options |
|
|
|
|
|
|
|
|
|
|
|
|
Exercise Price
(USD)
|
|
Number
Outstanding
|
|
Weighted-average
remaining contractual
life (years)
|
|
|
Options
Exercisable
|
|
$1.55
|
|
|
50,349
|
|
|
|
1.72
|
|
|
|
50,349
|
|
$2.20
|
|
|
2,165
|
|
|
|
2.30
|
|
|
|
2,165
|
|
$3.40
|
|
|
294,273
|
|
|
|
6.12
|
|
|
|
197,273
|
|
$3.72
|
|
|
40,000
|
|
|
|
2.44
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
386,787
|
|
|
|
5.14
|
|
|
|
249,787
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
1,272,931
|
|
|
|
4.32
|
|
|
|
763,165
|
|
|
The weighted-average remaining contractual life and weighted-average exercise price of options outstanding and of options exercisable as at December 31, 2019 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Canadian Dollar Denominated Options |
|
|
|
|
|
|
|
Number Outstanding |
|
|
Weighted-average
remaining contractual life (years) |
|
|
Options Exercisable |
|
$3.28 |
|
|
31,498 |
|
|
|
5.67 |
|
|
|
31,498 |
|
$4.50 |
|
|
18,936 |
|
|
|
3.28 |
|
|
|
18,936 |
|
$4.54 |
|
|
743,122 |
|
|
|
6.76 |
|
|
|
296,807 |
|
$4.80 |
|
|
3,040 |
|
|
|
0.71 |
|
|
|
3,040 |
|
$7.49 |
|
|
5,590 |
|
|
|
5.52 |
|
|
|
5,590 |
|
$9.00 |
|
|
11,481 |
|
|
|
5.52 |
|
|
|
11,481 |
|
$9.60 |
|
|
1,105 |
|
|
|
0.77 |
|
|
|
1,105 |
|
$11.70 |
|
|
6,667 |
|
|
|
0.94 |
|
|
|
6,667 |
|
$12.00 |
|
|
1,948 |
|
|
|
0.93 |
|
|
|
1,948 |
|
$30.00 |
|
|
28,260 |
|
|
|
1.65 |
|
|
|
28,260 |
|
$30.60 |
|
|
2,096 |
|
|
|
0.98 |
|
|
|
2,096 |
|
$32.40 |
|
|
810 |
|
|
|
1.08 |
|
|
|
810 |
|
$45.30 |
|
|
560 |
|
|
|
0.61 |
|
|
|
560 |
|
$51.60 |
|
|
5,266 |
|
|
|
0.44 |
|
|
|
5,268 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
860,379 |
|
|
|
4.37 |
|
|
|
414,066 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
US Dollar Denominated Options |
|
|
|
|
|
|
|
Number Outstanding |
|
|
Weighted-average remaining contractual life (years) |
|
|
Options Exercisable |
|
$1.55 |
|
|
50,349 |
|
|
|
1.97 |
|
|
|
50,349 |
|
$2.20 |
|
|
469,420 |
|
|
|
6.53 |
|
|
|
2,165 |
|
$3.40 |
|
|
294,273 |
|
|
|
6.37 |
|
|
|
197,273 |
|
$3.72 |
|
|
40,000 |
|
|
|
2.69 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
854,042 |
|
|
|
6.28 |
|
|
|
249,787 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
1,714,421 |
|
|
|
5.32 |
|
|
|
663,853 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summary of Options are Granted to Directors, Officers, Employees and Consultants |
|
Options are granted to Directors, Officers, Employees and Consultants at various times. Options are to be settled by physical delivery of shares. Options and the terms of each issue over the year ended December 31, 2019 are outlined below.
|
|
|
|
|
|
|
|
|
|
|
Number of Options |
|
|
|
|
Contractual Life of Options |
February 14, 2019, options granted to a Consultant |
|
|
40,000 |
|
|
Options may vest over a 15-month vesting schedule |
|
Cancelled |
|
|
|
|
May 29, 2019, options granted to a Director |
|
|
253,000 |
|
|
Options vest over a specified vesting period not exceeding 4 years |
|
7 years |
|
|
|
|
June 28, 2019, options granted to an Employee |
|
|
10,000 |
|
|
Options vest as to 1/3 of the total number of Options granted, every year from Grant Date |
|
7 years |
|
|
|
|
July 18, 2019, options granted to a Director |
|
|
25,719 |
|
|
Options vest immediately |
|
7 years |
|
|
|
|
July 19, 2019, options granted to an Employee |
|
|
467,255 |
|
|
Options vest as to 1/4 of the total number of Options granted, every year from Grant Date |
|
7 years |
|
|
|
|
July 19, 2019, options granted to a Consultant |
|
|
2,165 |
|
|
Options vest as to 1/3 of the total number of Options granted, every year from Grant Date |
|
7 years |
|
|
|
|
July 19, 2019, options granted to a Director |
|
|
41,273 |
|
|
Options vest immediately |
|
7 years |
|
|
|
|
September 9, 2019, options granted to a Consultant |
|
|
40,000 |
|
|
Options vest over a 15-month vesting schedule subject to achieving certain m ilestones. |
|
2.5 years |
|
Summary of Inputs Used in Measurement of Fair Values at Grant Date of Share Based Option Plan |
The weighted average inputs in the original currency of the grants (CDN$ or US$) used in the measurement of fair values at grant date of the share-based option grants for the three months ended March 31, 2020
and 2019 are as follows:
|
2020 - CDN
|
|
2019 – US
|
Fair Value calculated
|
CDN $0.43
|
|
-
|
Share price at grant
|
CDN $.62
|
|
-
|
Exercise price
|
CDN $0.66
|
|
-
|
Expected Option Life
|
3.5 years
|
|
-
|
Risk free interest rate
(based on government bonds)
|
1.41%
|
|
-
|
Expected Volatility
|
109.00%
|
|
-
|
Expected dividends
|
Nil
|
|
-
|
|
The weighted average inputs (in CDN$ or US$ as per the grant) used in the measurement of fair values at grant date of the share-based option plan are as follows:
|
|
|
|
|
|
|
|
|
2019 |
|
2019 |
|
2018 |
|
|
US $1.48 |
|
CDN $1.61 |
|
CDN $5.99 |
|
|
US $2.36 |
|
CDN $2.90 |
|
CDN $10.79 |
|
|
US $2.72 |
|
CDN $4.54 |
|
CDN $11.97 |
|
|
3.5 years |
|
3.4 years |
|
3 years |
Risk free interest rate (based on government bonds) |
|
1.50% |
|
1.43% |
|
1.90% |
|
|
97.90% |
|
98.10% |
|
90.12% |
|
|
Nil |
|
Nil |
|
Nil |
|